 Experimental toxoplasmosis vaccine tests Aotus monkeys Aotus lemurinus Panamanian night monkeys susceptibility Toxoplasma infection capacity immunity sufadiazine prophylaxis non-persistent vaccine animals susceptible infection mouse pathogenic mouse nonpathogenic Toxoplasma isolate calculated single bradyzoite mouth rise infection fatal days Chemoprophylaxis sulfadiazine mg day days animals fatal reactivation infection days treatment Vaccination doses Challenge animals Toxoplasma isolates monkeys year prolonged illness controls Safety tests vaccine nonpathogenic adults slight fever local inflammation juveniles infection Vaccination pregnant monkeys non-pathogenic fetuses newborn microphthalmia retinitis cataract monkeys Toxoplasma infants high susceptibility Toxoplasma low immunizability absence exposure lack selection Toxoplasma arboreal monkeys terrestrial animals area